Advertisement

Topics

Sangamo BioSciences, Inc. Company Profile

01:28 EDT 21st March 2019 | BioPortfolio

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical trials to evaluate safety and clinical effect of a treatment for HIV/AIDS and another Phase 1 trial to evaluate safety and clinical effect of a treatment for recurrent glioblastoma multiforme. Other therapeutic development programs are focused on neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFNs) for gene modification. Sangamo has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the company's web site at http://www.sangamo.com/.


News Articles [698 Associated News Articles listed on BioPortfolio]

Sangamo BioSciences: Aktie fällt - Enttäuschende Daten

Kulmbach (www.aktiencheck.de) - Sangamo BioSciences-Aktienanalyse von Michel Doepke vom Online-Anlegermagazin "Der Aktionär": Michel Doepke von "Der Aktionär" nimmt in einer aktuellen Aktienanalyse....

Sangamo BioSciences: Aktie vor Studiendaten im Aufwind

Kulmbach (www.aktiencheck.de) - Sangamo BioSciences-Aktienanalyse von Michel Doepke vom Online-Anlegermagazin "Der Aktionär": Michel Doepke von "Der Aktionär" nimmt in einer aktuellen Aktienanalyse....

Sangamo and TxCell Announce the Completion of the Acquisition by Sangamo of Majority of TxCell Ordinary Shares

Stéphane Boissel, CEO of TxCell, joins Sangamo as Executive Vice President, Corporate Strategy Regulatory News: Sangamo Therapeutics, Inc. (Nasdaq: SGMO) and TxCell S.A. (Paris:TXCL) today jointly...

Sangamo completes acquisition of TxCell

Sangamo Therapeutics, Inc. announced the completion of the acquisition of TxCell, SA. TxCell is now a subsidiary of Sangamo and has been delisted from the French stock market. “The acquisition of Tx...

Sangamo Closes TxCell Acquisition

US gene therapy group Sangamo Therapeutics has completed its purchase of French biotech TxCell, which will now operate as a subsidiary of Sangamo and remain in Valbonne.

Why Sangamo’s shares tanked by 48%

The collapse Sangamo Therapeutics’ shares, by 48%, after results of its Champions trial were released has raised questions about the...Read More... The post Why Sangamo’s shares tanked by ...

Sangamo Exec Gary Lee Joins Senti Bio as Chief Scientific Officer

Senti Biosciences has appointed Gary Lee to serve as chief scientific officer. Lee comes to the South San Francisco, CA, biotech from Sangamo Therapeutics, where he was vice president of cell therapy....

#news #biotech Ex-Pfizer I-O lead joins Sangamo as EVP of R&D

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ex-Pfizer I-O lead joins Sangamo as EVP of R&D .Sangamo Therapeutics has...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]

natelleONE

Isoproterenol hydrochloride [amneal biosciences llc]

Isoproterenol Hydrochloride Injection, USP Rx only Sterile Injection

Spherusol [nielsen biosciences, inc.]

These highlights do not include all the information needed to use Spherusol safely and effectively. See full prescribing information for Spherusol . Coccidioides immitis Spherule-Derived Skin Test Ant...

Natelle one [azur pharma, inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)

This is a single-arm, multi-site, single-dose, Phase 1/2 study to assess ST-400 in 6 subjects with transfusion-dependent β-thalassemia (TDT) who are ≥18 and ≤40 years of age. ST-400 is a ...

Companies [378 Associated Companies listed on BioPortfolio]

Sangamo BioSciences

Sangamo BioSciences develops and markets novel transcription factors capable of regulating genes. The company’s powerful Universal Gene Recognition™ technology enables the engineering of a particu...

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development p...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Sangamo BioSciences, Inc." on BioPortfolio

We have published hundreds of Sangamo BioSciences, Inc. news stories on BioPortfolio along with dozens of Sangamo BioSciences, Inc. Clinical Trials and PubMed Articles about Sangamo BioSciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sangamo BioSciences, Inc. Companies in our database. You can also find out about relevant Sangamo BioSciences, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record